SARS-CoV-2 B.1.1.7 reinfection after previous COVID-19 in two immunocompetent Italian patients.
作者信息
Novazzi Federica, Baj Andreina, Genoni Angelo, Spezia Pietro G, Colombo Alberto, Cassani Gianluca, Zago Cristian, Pasciuta Renee, Della Gasperina Daniela, Ageno Walter, Severgnini Paolo, Dentali Francesco, Focosi Daniele, Maggi Fabrizio
机构信息
Laboratory of Microbiology, ASST Sette Laghi, Varese, Italy.
Department of Medicine and Surgery, University of Insubria, Varese, Italy.
出版信息
J Med Virol. 2021 Sep;93(9):5648-5649. doi: 10.1002/jmv.27066. Epub 2021 May 15.
Abstract
摘要
相似文献
1
SARS-CoV-2 B.1.1.7 reinfection after previous COVID-19 in two immunocompetent Italian patients.两名免疫功能正常的意大利患者在先前感染新冠病毒后再次感染严重急性呼吸综合征冠状病毒2（SARS-CoV-2）B.1.1.7毒株。
J Med Virol. 2021 Sep;93(9):5648-5649. doi: 10.1002/jmv.27066. Epub 2021 May 15.
2
Sensitive Immunodetection of Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern 501Y.V2 and 501Y.V1.严重急性呼吸综合征冠状病毒 2 变种 501Y.V2 和 501Y.V1 的敏感免疫检测
J Infect Dis. 2021 Aug 16;224(4):616-619. doi: 10.1093/infdis/jiab278.
3
Imported SARS-CoV-2 Variant P.1 in Traveler Returning from Brazil to Italy.从巴西返回意大利的旅行者中发现的新冠病毒变异毒株P.1
Emerg Infect Dis. 2021 Apr;27(4):1249-1251. doi: 10.3201/eid2704.210183. Epub 2021 Feb 10.
4
Early assessment of diffusion and possible expansion of SARS-CoV-2 Lineage 20I/501Y.V1 (B.1.1.7, variant of concern 202012/01) in France, January to March 2021.2021 年 1 月至 3 月法国对 SARS-CoV-2 谱系 20I/501Y.V1（B.1.1.7，202012/01 关注变体）的扩散和可能扩大的早期评估。
Euro Surveill. 2021 Mar;26(9). doi: 10.2807/1560-7917.ES.2021.26.9.2100133.
5
Introduction of SARS-CoV-2 variant of concern 20h/501Y.V2 (B.1.351) from Malawi to Italy.从马拉维引入意大利的关注变异 SARS-CoV-2 20h/501Y.V2（B.1.351）。
Emerg Microbes Infect. 2021 Dec;10(1):710-712. doi: 10.1080/22221751.2021.1906757.
6
The basis of a more contagious 501Y.V1 variant of SARS-CoV-2.新冠病毒更具传染性的501Y.V1变种的基础。
Cell Res. 2021 Jun;31(6):720-722. doi: 10.1038/s41422-021-00496-8. Epub 2021 Apr 23.
7
First detection of SARS-CoV-2 spike protein N501 mutation in Italy in August, 2020.2020年8月在意大利首次检测到严重急性呼吸综合征冠状病毒2（SARS-CoV-2）刺突蛋白N501突变。
Lancet Infect Dis. 2021 Jun;21(6):e147. doi: 10.1016/S1473-3099(21)00007-4. Epub 2021 Jan 12.
8
SARS-CoV-2 reinfection in a healthcare professional in inner Sao Paulo during the first wave of COVID-19 in Brazil.巴西 COVID-19 疫情第一波期间，圣保罗市内陆地区一名医护人员二次感染 SARS-CoV-2。
Diagn Microbiol Infect Dis. 2021 Dec;101(4):115516. doi: 10.1016/j.diagmicrobio.2021.115516. Epub 2021 Aug 20.
9
Characterization of a Lineage C.36 SARS-CoV-2 Isolate with Reduced Susceptibility to Neutralization Circulating in Lombardy, Italy.意大利伦巴第地区流行的一种对中和抗体敏感性降低的谱系 C.36 SARS-CoV-2 分离株的特征。
Viruses. 2021 Jul 31;13(8):1514. doi: 10.3390/v13081514.
10
First Identified Cases of SARS-CoV-2 Variant B.1.1.7 in Minnesota - December 2020-January 2021.明尼苏达州 2020 年 12 月至 2021 年 1 月期间发现的首例 SARS-CoV-2 变异株 B.1.1.7 。
MMWR Morb Mortal Wkly Rep. 2021 Feb 26;70(8):278-279. doi: 10.15585/mmwr.mm7008e1.
引用本文的文献
1
SARS-CoV-2 reinfections during the first three major COVID-19 waves in Bulgaria.SARS-CoV-2 再感染在保加利亚前三次 COVID-19 大流行期间。
PLoS One. 2022 Sep 9;17(9):e0274509. doi: 10.1371/journal.pone.0274509. eCollection 2022.
2
Reinfection in patients with COVID-19: a systematic review.COVID-19 患者再感染：系统评价。
Glob Health Res Policy. 2022 Apr 29;7(1):12. doi: 10.1186/s41256-022-00245-3.
3
Research progress on vaccine efficacy against SARS-CoV-2 variants of concern.关于针对 SARS-CoV-2 关切变异株疫苗效力的研究进展。
Hum Vaccin Immunother. 2022 Nov 30;18(5):2057161. doi: 10.1080/21645515.2022.2057161. Epub 2022 Apr 19.
4
COVID-19 reinfection in Liberia: Implication for improving disease surveillance.利比里亚的 COVID-19 再感染：对改善疾病监测的启示。
PLoS One. 2022 Mar 24;17(3):e0265768. doi: 10.1371/journal.pone.0265768. eCollection 2022.
5
Clinical and Infection Prevention Applications of Severe Acute Respiratory Syndrome Coronavirus 2 Genotyping: An Infectious Diseases Society of America/American Society for Microbiology Consensus Review Document.严重急性呼吸综合征冠状病毒 2 基因分型的临床和感染预防应用：美国传染病学会/美国微生物学会共识审查文件。
Clin Infect Dis. 2022 Apr 28;74(8):1496-1502. doi: 10.1093/cid/ciab761.
6
Clinical and Infection Prevention Applications of Severe Acute Respiratory Syndrome Coronavirus 2 Genotyping: an Infectious Diseases Society of America/American Society for Microbiology Consensus Review Document.严重急性呼吸系统综合征冠状病毒 2 基因分型的临床和感染预防应用：美国传染病学会/美国微生物学会共识审查文件。
J Clin Microbiol. 2022 Jan 19;60(1):e0165921. doi: 10.1128/JCM.01659-21. Epub 2021 Nov 3.
7
Complexities in Case Definition of SARS-CoV-2 Reinfection: Clinical Evidence and Implications in COVID-19 Surveillance and Diagnosis.严重急性呼吸综合征冠状病毒2型再次感染病例定义的复杂性：临床证据及其在2019冠状病毒病监测与诊断中的意义
Pathogens. 2021 Sep 29;10(10):1262. doi: 10.3390/pathogens10101262.
8
Cold atmospheric plasma: A non-negligible strategy for viral RNA inactivation to prevent SARS-CoV-2 environmental transmission.冷大气等离子体：一种不可忽视的用于病毒RNA失活以预防SARS-CoV-2环境传播的策略。
AIP Adv. 2021 Aug 10;11(8):085019. doi: 10.1063/5.0060530. eCollection 2021 Aug.
本文引用的文献
1
Imported SARS-CoV-2 Variant P.1 in Traveler Returning from Brazil to Italy.从巴西返回意大利的旅行者中发现的新冠病毒变异毒株P.1
Emerg Infect Dis. 2021 Apr;27(4):1249-1251. doi: 10.3201/eid2704.210183. Epub 2021 Feb 10.
2
Confirmed Reinfection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variant VOC-202012/01.确诊再次感染严重急性呼吸综合征冠状病毒2（SARS-CoV-2）变异株VOC-202012/01。
Clin Infect Dis. 2021 Nov 16;73(10):1946-1947. doi: 10.1093/cid/ciab014.
Zotero 插件